Piramal Critical Care (PCC), a unit of Piramal Enterprises, is one of the market leaders in the global inhalation anesthetic market.
PCC maintains a wide presence across the USA, Europe and more than 100 countries across the globe. Our rich product portfolio includes Inhalation Anesthetics such as Sevoflurane, Isoflurane and Halothane as well as Intrathecal Baclofen therapy, for spasticity management. PCC has wholly owned, state-of-the-art manufacturing facilities in the US and India that are inspected periodically by the US FDA, UK MHRA and other regulators.
Our core strength lies in our highly qualified global workforce of more than 250 employees across 16 countries. PCC is focused on further expanding its global footprint through new product additions in the critical care space.Visit Website
Pharma Solutions is one of the largest manufacturing companies in the world that provides tractability and scalability of operations.Read More
The healthcare vertical has a Consumer Product Division, and is one of the fastest emerging players in the Domestic Consumer Healthcare market.Read More
Providing innovative diagnostic imaging agents, the Imaging Division aims to serve patients better, using world-class technology through our subsidiary.Read More
PhytoMedicine™ develops and markets standardised healthcare solutions derived from natural sources such as plants.Read More